Lactation

Herbal medicinal product: Foeniculi dulcis fructusArray, F: Assessment finalised

Retrieved on: 
Mardi, mars 12, 2024

Herbal medicinal product: Foeniculi dulcis fructusArray, F: Assessment finalised

Key Points: 


Herbal medicinal product: Foeniculi dulcis fructusArray, F: Assessment finalised

Momcozy Announces Exciting Partnership With Boots

Retrieved on: 
Mercredi, mars 6, 2024

Boots, the UK's fastest-growing health and beauty retailer, has announced its partnership with Momcozy, the maker of the ultra-popular M5 Wearable Breast Pump as well as a wide range of maternity care products.

Key Points: 
  • Boots, the UK's fastest-growing health and beauty retailer, has announced its partnership with Momcozy, the maker of the ultra-popular M5 Wearable Breast Pump as well as a wide range of maternity care products.
  • As the industry-leading wearable breast pump manufacturer, Momcozy brings its highly sought-after pumping and nursing bras, lactation massager, and more to Boots' online marketplace, making quality maternity products more accessible throughout the UK.
  • View the full release here: https://www.businesswire.com/news/home/20240306523882/en/
    Momcozy Announces Exciting Partnership With Boots (Photo: Business Wire)
    Momcozy’s first shot to fame was in 2018 with their all-in-one M5 Wearable Breast Pump , which revolutionized pumping by creating a virtually pain-free and discreet way to express anytime, anywhere.
  • Endorsed by 3 million mothers in over 40 countries, Momcozy is a companion to women from pregnancy to early motherhood.

The State of Feeding Survey Reveals Only 40% of New Moms Meet Personal Baby Feeding Expectations, Highlighting an Alarming Gap in Baby Feeding Education and Support

Retrieved on: 
Mardi, mars 5, 2024

SAN FRANCISCO and ITHACA, N.Y., March 5, 2024 /PRNewswire/ -- In a step towards empowering parents' diverse feeding journeys, Willow Innovations, Inc. (Willow), the leading FemTech brand changing how moms breastfeed; Bobbie, the mom-founded pediatric nutrition company; and SimpliFed, a digital lactation consultant network democratizing feeding support, released the findings from their inaugural State of Feeding Survey and Report. These findings are the culmination of a rare partnership that closes the divide within the baby-feeding industry and marks a significant stride in creating a holistic and inclusive approach to support mothers. The State of Feeding survey data underscores the feeding realities of new moms to redefine expectations and allow parents to embrace their unique journeys on their terms.

Key Points: 
  • The State of Feeding survey data underscores the feeding realities of new moms to redefine expectations and allow parents to embrace their unique journeys on their terms.
  • According to the State of Feeding survey, nearly 100% of prepartum and postpartum moms had a plan for how they would feed their babies.
  • 11% of moms intended for a combination of feeding (also known as "Combo Feeding") with breastfeeding, pumping, and formula feeding; however, 65% were combination feeding.
  • Moms who formula feed or pump are less likely to receive support and education, despite the majority of moms are combination feeding.

Labroots Announces Agenda for its 7th Annual Drug Discovery & Development Virtual Event on February 21, 2024

Retrieved on: 
Jeudi, février 15, 2024

YORBA LINDA, Calif., Feb. 15, 2024 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual and hybrid events and webinars, today announced its 7th annual event in the Drug Discovery & Development Virtual Event Series. Hosted on February 21st and free to attend, attendees will experience the forefront of pharmaceutical innovation joining industry and academic leaders from around the world debating the latest, insightful scientific breakthroughs in this ever-evolving field.

Key Points: 
  • Focusing from pre-clinical development to clinical development, advances in the field of drug discovery and development will be explored shaping current and future challenges in drug research
    YORBA LINDA, Calif., Feb. 15, 2024 /PRNewswire-PRWeb/ -- Labroots , the leading scientific social networking website offering premier, interactive virtual and hybrid events and webinars, today announced its 7th annual event in the Drug Discovery & Development Virtual Event Series .
  • The 2024 informative agenda covers a range of sessions spanning areas including Emerging Modalities in Drug Discovery and Preclinical Development, New Methods in Pharmacogenomics, and Biomarker Applications.
  • Use the hashtag #LRdrug to follow the conversation and connect with other members of the global Drug Discovery & Development community!
  • Follow @DrugDiscoveryLR on Twitter and @DrugDiscoveryandDevelopment on Facebook to connect with our specialist Drug Discovery & Development writers and stay up to date with the latest Trending News in Drug Discovery & Development.

Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients

Retrieved on: 
Mardi, février 13, 2024

Given that most Erosive GERD patients have already undergone treatment with a PPI, and many continue to express dissatisfaction with their current regimens, we are pleased with this outcome.

Key Points: 
  • Given that most Erosive GERD patients have already undergone treatment with a PPI, and many continue to express dissatisfaction with their current regimens, we are pleased with this outcome.
  • doi:10.1136/ bmjgast-2022-000941
    VOQUEZNA® (vonoprazan) is a potassium-competitive acid blocker (PCAB) indicated:
    for the healing of all grades of Erosive Esophagitis (Erosive Gastroesophageal Reflux Disease or Erosive GERD) and relief of heartburn associated with Erosive GERD in adults.
  • for the maintenance of healing of all grades of Erosive GERD and relief of heartburn associated with Erosive GERD in adults.
  • Renal Impairment: For the healing of Erosive GERD, dosage reduction is recommended in patients with severe renal impairment (eGFR

Harbor Raises $3.7MM in Seed Funding to Revolutionize the Smart Baby Monitor & Sleep Technology Space

Retrieved on: 
Jeudi, février 1, 2024

Lavelle partnered with co-founder and CPO Charlie Hill to begin an intensive product development cycle to revolutionize key attributes that had been overlooked in the infant monitoring space.

Key Points: 
  • Lavelle partnered with co-founder and CPO Charlie Hill to begin an intensive product development cycle to revolutionize key attributes that had been overlooked in the infant monitoring space.
  • Parents and kids deserve a secure, reliable, quality baby monitor, and since none exist, Harbor has built just that."
  • We've experienced so much raising our kids and know Harbor will make a huge difference for parents everywhere," says investor, Thomas Morstead.
  • Starting in February 2024, Harbor will launch a waitlist campaign to offer early access to its innovative device and services.

New Postnatal Retreat Sanu Advances Postpartum Recovery and Support for Families in the Greater Washington D.C. Area

Retrieved on: 
Mercredi, janvier 31, 2024

TYSONS, Va., Jan. 31, 2024 /PRNewswire/ -- Sanu, the first physician-developed luxury postnatal retreat providing elevated postpartum recovery and support, has opened at The Watermark Hotel in Tysons, VA. Sanu is currently booking reservations for families welcoming newborns in 2024.

Key Points: 
  • Sanu Postnatal Retreat unites a physician-developed, mother-first program with serene luxury for an exceptional postpartum recovery experience.
  • TYSONS, Va., Jan. 31, 2024 /PRNewswire/ -- Sanu , the first physician-developed luxury postnatal retreat providing elevated postpartum recovery and support, has opened at The Watermark Hotel in Tysons, VA. Sanu is currently booking reservations for families welcoming newborns in 2024.
  • Inspired by her Korean roots, Kim has modeled the retreat after South Korea's "Sanhujori" concept of postpartum care centers and the traditional "Sam Chil Il" 21-day healing period.
  • To support physical and mental health, skill-building, and a comfortable, productive recovery, the Sanu Postnatal Retreat offers evidence-based programming supported by personalized, full-service, round-the-clock care and luxurious comforts for new moms and their families.

Providence Saint John's Health Center and Mahmee Partner to Expand Breastfeeding Services and Enhance Maternal Health Care

Retrieved on: 
Jeudi, janvier 11, 2024

Providence Saint John's Health Center is today announcing a partnership with Mahmee, a wraparound maternal healthcare company, to expand lactation care, enrich the postpartum experience and provide seamless support for new parents when they leave the hospital.

Key Points: 
  • Providence Saint John's Health Center is today announcing a partnership with Mahmee, a wraparound maternal healthcare company, to expand lactation care, enrich the postpartum experience and provide seamless support for new parents when they leave the hospital.
  • In the month following delivery, Providence Saint John’s patients will have access to a complimentary Mahmee membership.
  • By working with Mahmee, we are expanding our impact on families by offering essential support services, including mental health care and remote patient monitoring."
  • While Providence Saint John's has long championed maternal health care support, the partnership with Mahmee marks a monumental stride in creating a safety net during the most vulnerable phase of childbirth: the postpartum period.

Lexicon Pharmaceuticals Provides Business and Pipeline Update at 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Lundi, janvier 8, 2024

THE WOODLANDS, Texas, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives, today announced a business and pipeline update at the 42nd Annual J.P. Morgan Healthcare Conference taking place January 8-12, 2024.

Key Points: 
  • THE WOODLANDS, Texas, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives, today announced a business and pipeline update at the 42nd Annual J.P. Morgan Healthcare Conference taking place January 8-12, 2024.
  • “Lexicon achieved major advancements in 2023 in its business and pipeline of pharmaceutical innovations,” said Lonnel Coats, chief executive officer and director of Lexicon.
  • The company will also focus on ensuring a strong ongoing awareness of INPEFA in the medical community through medical publications and congress presence.
  • Company to Present at J.P. Morgan Healthcare Conference Thursday, January 11, 2024 at 10:30am PST (1:30pm ET)
    Lonnel Coats, Lexicon’s chief executive officer, will make a company presentation.

Empowering Moms Throughout 2023: The Year of Momcozy's Dedication

Retrieved on: 
Samedi, janvier 6, 2024

This powerful piece brought real mothers' voices and stories to the forefront, sparking a global conversation about the realities of motherhood.

Key Points: 
  • This powerful piece brought real mothers' voices and stories to the forefront, sparking a global conversation about the realities of motherhood.
  • Additionally, our product giveaways brought more tangible support to breastfeeding moms to care for breastfeeding moms.
  • We also launched the Cozy Case with a kneading lactation massager, nipple cream, and breastmilk storage bags to care for breastfeeding moms.
  • As we wrap up 2023, we reflect on how Momcozy has been more than just a brand, but a true companion for moms.